Daiichi Sankyo Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.
The item "Total-Revenue" stands at 1.92 Trillion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the highest value at least since 12/31/2011, the period currently displayed.
Daiichi Sankyo Co. Ltd.'s first quarter result of 0.4746 Trillion JPY for the item "Total Revenue" represents a decrease of -8.50 percent compared to it's fourth quarter result of the company's last fiscal year.
Also, Daiichi Sankyo Co. Ltd.'s first quarter result of 0.4746 Trillion JPY for the item "Total Revenue" represents an increase of 8.81 percent compared to it's first quarter result of last year.
Looking again at the trailing twelve months series (TTM), Daiichi Sankyo Co. Ltd.'s first quarter result of 1.92 Trillion JPY for the item "Total Revenue" represents an increase of 2.04 percent compared to it's fourth quarter result of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 14.09 percent compared to the value the year prior.
The 1 year change in percent is 14.09.
The 3 year change in percent is 81.38.
The 5 year change in percent is 98.52.
The 10 year change in percent is 113.06.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Revenue | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Revenue | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Revenue | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Revenue | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Revenue | 280,205,508,085.11 |